In many high burden countries, patients with TB symptoms seek care from diverse care providers, outside the current scope of the National Tuberculosis Control Programme. Non-NTP providers usually do not apply efficient diagnosis strategies nor do they follow the DOTS strategy, thus hampers case detection, delays diagnosis, results in sub-standard treatment, increases risk for drug resistance and/or puts an excessive financial burden on patients. WHO recommends in the new Stop TB Strategy to engage non-NTP providers and scale up PPM DOTS initiative